NORMEDI DANMARK ApS: Financial statements 2017
CVR: 35663290
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NORMEDI DANMARK ApS (CVR 35663290) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 789,454 and a net result of DKK -32,322 compared with DKK 131,378 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2017 report amounted to DKK 56. The solvency ratio was 0%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 789,454
- Profit/Loss
- DKK -32,322
- Equity
- DKK 56
- Total Assets
- DKK 753,605
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 789 t. | -32 t. | 56 | 1 |
| 2016 | - | 850 t. | 131 t. | 32 t. | 1 |
| 2015 | - | - | 0 | 0 | - |
| 2014 | - | 616 t. | 70 t. | 120 t. | - |
Official annual report
Keep an eye on NORMEDI DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NORMEDI DANMARK ApS has published its annual report for 2016. Gross profit came to DKK 850,070, and the net result was DKK 131,378.
About NORMEDI DANMARK ApS
NORMEDI DANMARK ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ApS STAKE NR. 5035. The management consists of Jesper Steffensen. The board consists of Michelangelo Stefani (chair), Jesper Steffensen and Joao Malagueira. The company is owned by Hologic GGO 4 Ltd. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,460,197 and a net result of DKK 386,079 compared with DKK -74,099 the year before. Equity in the 2025 report amounted to DKK 1,852,127.